You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Your window into Astellas’ world of patient-centered and science-driven healthcare, as told by the experts who bring it to life.
In cancer care, progress doesn't always come in big, dramatic breakthroughs. More often, it happens in quieter moments, when people stop, talk through new data, and try to make sense of what it really means for patients.
That's what makes gatherings like ASCO so important. It's not just about sharing results. It's about the conversations that follow and where science starts to connect with real life.
Tadaaki Taniguchi
Chief Research &
Development Officer (CRDO)
There's a lot happening in cancer research. New findings, new approaches, new questions. It's moving fast—which is exciting, but also challenging.
Because data on its own doesn't tell the full story. As treatment decisions become more complex, clinicians still need to understand what it means for the people sitting across from them in the clinic.
"Generating data is only part of the job," Tadaaki Taniguchi, Chief Research & Development Officer explains. "What matters most is interpreting it in context so we can translate scientific progress into better care for patients."
At ASCO, that understanding takes shape in many ways. It is not just during presentations, but in hallway conversations, poster sessions and informal exchanges between peers.
This year, Astellas is contributing research across several areas of oncology, from advanced disease to earlier treatment settings and ongoing pipeline work. But it's not just about the number of studies.
It's about how everything fits together.
Scientific understanding builds over time. A result today becomes clearer with longer follow-up. Early findings raise new questions. Different patient groups can reveal important nuances in how data is interpreted.
And all of this helps clinicians work through questions they face every day:
Claus Zieler
Chief Commercial & Medical
Affairs Officer (CCMAO)
That's where conversation makes a difference.
At ASCO, data gets discussed, challenged, and shared through lived experience. People bring their own perspectives from clinical practice, and this helps turn information into something more meaningful.
"Data shouldn't just sit on a screen or a poster," Claus Zieler, Chief Commercial and Medical Affairs Officer says. "Discussions and interpretations are what turn evidence into decisions that can bring innovation closer to the patients who need it."
For Astellas, being part of ASCO is about contributing to that broader exchange.
With a long-standing focus in oncology, the goal isn't just to share research—but to help shape how it is understood, interpreted and applied in practice. To listen, to engage, and to learn alongside the oncology community.
Because progress doesn't happen in isolation. It happens when people build on each other's work and keep asking better questions.
ASCO is just one moment, but it's an important one.
Each conversation helps move things forward, bringing more clarity to complex questions, and helping turn new knowledge into better decisions.
And behind all of it are patients, waiting for clearer answers, more options, and progress that makes a real difference.
That's what keeps the conversation going—and how progress moves from data to decisions that matter for patients.
Follow us
